SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·07/28/2025 12:08:27
Listen to the news
Gainers
- Celcuity (NASDAQ:CELC) stock rose 241.8% to $47.06 during Monday's pre-market session. The market value of their outstanding shares is at $521.4 million.
- CervoMed (NASDAQ:CRVO) stock rose 41.31% to $12.69. The company's market cap stands at $78.1 million.
- Innate Pharma (NASDAQ:IPHA) stock increased by 17.73% to $2.39. The company's market cap stands at $187.0 million.
- Celularity (NASDAQ:CELU) shares moved upwards by 17.69% to $3.48. The company's market cap stands at $70.8 million.
- Abpro Hldgs (NASDAQ:ABP) stock moved upwards by 17.31% to $0.37. The company's market cap stands at $19.1 million.
- Healthcare Triangle (NASDAQ:HCTI) stock increased by 17.22% to $0.08. The market value of their outstanding shares is at $27.9 million.
Losers
- Adaptimmune Therapeutics (NASDAQ:ADAP) stock decreased by 36.6% to $0.22 during Monday's pre-market session. The market value of their outstanding shares is at $91.9 million.
- Alterity Therapeutics (NASDAQ:ATHE) shares fell 16.04% to $5.5. The company's market cap stands at $96.9 million.
- 180 Life Sciences (NASDAQ:ATNF) shares fell 13.34% to $2.6. The market value of their outstanding shares is at $18.1 million. As per the press release, Q2 earnings came out 3 days ago.
- Calidi Biotherapeutics (AMEX:CLDI) stock fell 11.4% to $0.65. The market value of their outstanding shares is at $25.2 million.
- Camp4 Therapeutics (NASDAQ:CAMP) shares fell 9.19% to $1.64. The company's market cap stands at $36.4 million.
- Revvity (NYSE:RVTY) shares fell 7.4% to $96.0. The company's market cap stands at $12.2 billion. As per the press release, Q2 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.